This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

GI bleeding prophylaxis in critically ill patients

Authoring team

There is evidence that anti-ulcer treatment reduces the incidence of gastrointestinal bleeding.

Primary prophylaxis for acutely ill patients in critical care

  • acid-suppression therapy (H2-receptor antagonists or proton pump inhibitors) should be offered for primary prevention of upper gastrointestinal bleeding in acutely ill patients admitted to critical care. If possible, the oral form of the drug should be used
  • the need for ongoing acid-suppression drugs for primary prevention of upper gastrointestinal bleeding in acutely ill patients should be reviewed when they recover or are discharged from critical care

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.